detectability of drug tablets and capsules by plain radiography

11
Detectability of DrugTabletsand Capsules by Plain Radiography RICHARD P. O’BRIEN, MD, PAUL A. McGEEHAN, MD, ALBERT W. HELMECZI, RPh, DAVID J. DULA, MD This study was undertaken to determine the detectability of drugs in tablet or capsule form by plain radiography. A total of 459 drugs in tablet or capsule form were radiographed in water with parameters commonly used in routine upper abdominal films. Detectability was judged subjectively by radiologist’s readings and objectively by the use of a densitometer. Of the total, 6.3% were as radiopaque as a ferrous sulfate control tablet, 29.6% were moderately radiopaque, but less than control values, and 64% were essentially nondetectable. Potential benefits of this information in the clinical setting are discussed. (Am J Emerg Med 1988;4:302-312) Although it is common knowledge that some cap- sules and tablets are reliably detected by plain radiog- raphy, no complete or current attempt has been made to identify and catalog them. The only currently avail- able compilation of radiographically detectable medi- cation was published over 14 years ago by Handy,’ who evaluated only 211 medications. METHODS A total of 459 medications including prescription and over-the-counter drugs in tablet and capsule form were obtained using the Geisinger Medical Center Formulary and information supplied by several local pharmacies in Northeastern Pennsylvania as a guide. An attempt was made to include as many commonly prescribed medications in their various formulations as feasible, and to include several recently released drugs. Our premise was that one intact capsule or tablet would be detectable on the abdominal radiograph. Only intact medications were used for purposes of standardization. As a model, we chose to use the method of Handy. Each medication was radiographed in 20 cm of water to simulate its appearance as might be seen on a routine film of the abdomen. With radio- From the Departments of Emergency Medicine, Radiology, and Pharmacy, Geisinger Medical Center, Danville, Pennsylvania. Manuscript received November 12, 1985; revision accepted Jan- uary 2, 1986. Address reprint requests to Dr. Dula: Department of Emergency Medicine, Geisinger Medical Center, Danville, PA 17822. Key Words: Drugs, overdose, radio-opacity, toxicology. 0735-6757186 $00.00 + .25 302 lucent glue, 38 drugs at a time were positioned on a clear piece of x-ray film to which lead numbers and letters were affixed creating a 40-point grid (Fig. 1). Each grid had two remaining points containing a nega- tive (empty point with the glue applied to the film) and a positive (ferrous sulfate2v3 300 mg tablet) control. Cold water to a depth of 20 cm was put in a large plastic container, the bottom of which was composed solely of 5-mil-thick clear plastic (Fig. 2). The test grids were suspended in the water at a depth of 10 cm, which was also 10 cm above a standard x-ray table. Exposures were made consistently at appropriate set- tings (0.4 seconds, 250 mA, 60 KV) on the same radio- graphic equipment (Phillips Diagnost 73), with a tube- to-table distance of 40 cm. Irregularly shaped drugs were placed on the grid so that the thinnest dimension of the tablet or capsule was perpendicular to the x-ray beam to insure uniformity. Tabulation of results was done as follows. Each film was read by four board-certified radiologists. The film reader was informed that point E8 on each film con- tained a ferrous sulfate tablet. The reader was not told the identity of any other drug on the film. He was also informed that point E7 always contained a nondetect- able drug (actually the negative control) for compar- ison purposes. A grading system for x-ray detect- ability was used where grade 0 is less dense than background, grade 1 + is minimally or nondetectable, grade 2 + is detectable but less so than ferrous sulfate controls, grade 3 + is detectable comparable with ferrous sulfate control, and grade 4+ is more radio- paque than the ferrous sulfate control (Table 1). 298 cm 238 cm FIGURE 1. Diagram of 40-point grid to which the drugs tested were attached (38 at a time).

Upload: david-j

Post on 31-Dec-2016

249 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Detectability of drug tablets and capsules by plain radiography

Detectability of Drug Tablets and Capsules by Plain Radiography

RICHARD P. O’BRIEN, MD, PAUL A. McGEEHAN, MD, ALBERT W. HELMECZI, RPh, DAVID J. DULA, MD

This study was undertaken to determine the detectability of drugs in tablet or capsule form by plain radiography. A total of 459 drugs in tablet or capsule form were radiographed in water with parameters commonly used in routine upper abdominal films. Detectability was judged subjectively by radiologist’s readings and objectively by the use of a densitometer. Of the total, 6.3% were as radiopaque as a ferrous sulfate control tablet, 29.6% were moderately radiopaque, but less than control values, and 64% were essentially nondetectable. Potential benefits of this information in the clinical setting are discussed. (Am J Emerg Med 1988;4:302-312)

Although it is common knowledge that some cap- sules and tablets are reliably detected by plain radiog- raphy, no complete or current attempt has been made to identify and catalog them. The only currently avail- able compilation of radiographically detectable medi- cation was published over 14 years ago by Handy,’ who evaluated only 211 medications.

METHODS

A total of 459 medications including prescription and over-the-counter drugs in tablet and capsule form were obtained using the Geisinger Medical Center Formulary and information supplied by several local pharmacies in Northeastern Pennsylvania as a guide. An attempt was made to include as many commonly prescribed medications in their various formulations as feasible, and to include several recently released drugs.

Our premise was that one intact capsule or tablet would be detectable on the abdominal radiograph. Only intact medications were used for purposes of standardization. As a model, we chose to use the method of Handy. Each medication was radiographed in 20 cm of water to simulate its appearance as might be seen on a routine film of the abdomen. With radio-

From the Departments of Emergency Medicine, Radiology, and Pharmacy, Geisinger Medical Center, Danville, Pennsylvania.

Manuscript received November 12, 1985; revision accepted Jan- uary 2, 1986.

Address reprint requests to Dr. Dula: Department of Emergency Medicine, Geisinger Medical Center, Danville, PA 17822.

Key Words: Drugs, overdose, radio-opacity, toxicology.

0735-6757186 $00.00 + .25

302

lucent glue, 38 drugs at a time were positioned on a clear piece of x-ray film to which lead numbers and letters were affixed creating a 40-point grid (Fig. 1). Each grid had two remaining points containing a nega- tive (empty point with the glue applied to the film) and a positive (ferrous sulfate2v3 300 mg tablet) control. Cold water to a depth of 20 cm was put in a large plastic container, the bottom of which was composed solely of 5-mil-thick clear plastic (Fig. 2). The test grids were suspended in the water at a depth of 10 cm, which was also 10 cm above a standard x-ray table. Exposures were made consistently at appropriate set- tings (0.4 seconds, 250 mA, 60 KV) on the same radio- graphic equipment (Phillips Diagnost 73), with a tube- to-table distance of 40 cm. Irregularly shaped drugs were placed on the grid so that the thinnest dimension of the tablet or capsule was perpendicular to the x-ray beam to insure uniformity.

Tabulation of results was done as follows. Each film was read by four board-certified radiologists. The film reader was informed that point E8 on each film con- tained a ferrous sulfate tablet. The reader was not told the identity of any other drug on the film. He was also informed that point E7 always contained a nondetect- able drug (actually the negative control) for compar- ison purposes. A grading system for x-ray detect- ability was used where grade 0 is less dense than background, grade 1 + is minimally or nondetectable, grade 2 + is detectable but less so than ferrous sulfate controls, grade 3 + is detectable comparable with ferrous sulfate control, and grade 4+ is more radio- paque than the ferrous sulfate control (Table 1).

298 cm

238 cm

FIGURE 1. Diagram of 40-point grid to which the drugs tested were attached (38 at a time).

Page 2: Detectability of drug tablets and capsules by plain radiography

O’BRIEN ET AL W DETECTABILITY OF TABLETS AND CAPSULES

In addition, densitometry readings using a Digital Densitometer II’s’ (Nuclear Associates, Inc., Carle Place, New York) were performed on each film in an attempt to objectively grade the radiodensity of each drug. These measurements proved to be less useful than expected because the optical density varied in magnitude less than the calibration of the densitom- eter at random points on all films and from film to film. These readings are presented in our tables of re- sults but were not relied upon to grade the drugs under study.

RESULTS

Using the premise that drugs with a radiopacity ap- proximately comparable with or greater than ferrous sulfate are reliably detectable by plain radiography, we list all medications that were consistently graded as 3 + or 4+ as such in Table 2. It should be noted that in this category (as well as in the categories that follow), there was almost unanimous agreement among our film readers in scoring each individual drug. A total of 29 drugs (including our control), or 6.3% of the total studied, met this criteria. For the sake of completeness, Table 2 also contains a list of four medications not considered in our study that re- ceived a similar evaluation by Handy.’

Drugs that were rated in the 2 + category might well be described as moderately detectable. In the clinical setting, we believe any expectation of seeing one of these preparations on a film of the upper abdomen would be at least somewhat suspect. A total of 136 medications, or 29.6% of the total studied, met this criteria (Table 3).

Drugs rated as either 0 or 1 + by our readers are grouped together as essentially nondetectable. A total of 294 preparations (64%) were judged to be in this category (Table 4).

DISCUSSION

Drug overdose is a common problem in emergency medicine, and the emergency physician may need to

SuSPended preproces

FIGURE 2. Diagram of the plastic container in which drugs were tested for radiopacity.

TABLE 1. Grading Scale for Radiopacity of Drugs

Grade Explanation

0 Less dense than background 1+ Not or minimally detectable 2+ Radiopacity less than ferrous sulfate control

but greater than 1 + 3+ Radiopacity approximately comparable

with ferrous sulfate control 4+ Radiopacity greater than ferrous

sulfate control tablet -

determine whether a drug was taken or how much of the drug remains in the stomach after gastric lavage or emesis with ipecac. Patient histories are frequently in- accurate or unobtainable, and it is not unusual for treatment of ingestions to be begun empirically. As an adjunctive diagnostic measure in this problem, the de- tection of drugs by radiology of the abdomen can be considered. This intervention is rapid, safe, and easy to perform, and can yield valuable information to the physician if the drug is radiopaque. Having a refer- ence list of drugs that are known to be radiopaque could guide the emergency physician to obtain radio- graphs of the abdomen of overdose victims who have taken substances that they expect to be visualized. Prior to this study, only a partial and outdated list of such drugs was available for referencing. With the in- formation contained in this study, the emergency phy- sician should be able to judge which patients who have ingested drugs may benefit from a radiograph of the abdomen. While the indiscriminate use of the x-ray film of the abdomen on potential overdose victims may occasionally provide useful information, the spe- cific use of this x-ray film on patients who have in- gested radiopaque drugs will provide a higher yield and be more cost-effective. In addition to aiding the emergency physician in determining whether an over- dose has occurred, a radiograph of the abdomen, if positive, may help to determine the amount of drug that has been taken. A repeat radiograph of an over- dose patient with radiopaque drug fragments will help determine the efficacy of gastric emptying and identify those patients who require further treatment to empty the stomach. However, a negative abdominal radio- graph in the setting of a suspected overdose, even if radiopaque material has been ingested, must not be over-interpreted. Dissolution of the fragments in the gastric fluid may render them radiolucent and result in a false-negative result. Thus, the dissolution time of medication is also an important parameter in their ra- diographic detectability and has not been taken into account in this study. Similarly disintegration of pills or tablets may occur, resulting in a homogeneous mix- ture in the stomach that would be undetectable on a radiograph.

303

Page 3: Detectability of drug tablets and capsules by plain radiography

AMERICAN JOURNAL OF EMERGENCY MEDICINE n Volume 4, Number 4 D July 1986

TABLE 2. Drugs with a Radiopacity Approximately Comparable with or Greater than Ferrous Sulfate Control

Generic Name Brand Name Strength Form Manufacturer

Optical

Density

(Urll&)

Bethanechol

Busulfan

Calcium carbonate

Calcium carbonate

Calcium carbonate

Chloral hydrate Chlorpheniraminei

phenylephrine

Ephedrine/phenobarbital/

theophylline Ferrous fumaratel

ascorbic acid

Ferrous fumaratel

ascorbic acid

Ferrous fumarate/

ascorbic acid

Ferrous sulfate

Ferrous sulfate

Glyburide

Haloperidol

Liothyronine Meclizine

Phosphorus

Potassium chloride Potassium chloride

Potassium chloride

Simethicone/pancreatic enzymes

Sodium chloride

Sodium fluoride/

calcium carbonate

Spironolactone Trifluoperazine

Vitaminsifolic acid

Vitamins/minerals/iron

Vitamins multiple

Vitamins multiple/minerals Zinc sulfate

Previously reported drugs* Ammonium chloride

lopanoic Acid Potassium iodide

Potassium permanganate

Duvoid

Myleran

Oscal

Oscal -

Noctec Demazin

Quadrinal

Ferancee-HP

Vitron C

Vitron C Plus

Slow Fe

Generic

Micronase

Haldol

Cytomel Antivert

Neutraphos

Slow K Kaon Cl K Tab

Phazyme 95

-

Florical

Aldactone Stelazine

Stuart Natal 1 + 1

Tabron

Stuart Natal One-A-Day Maximum -

-

Telepaque -

-

50 mg

2mg 250 mg

500 mg

650 mg

500 mg

24 mgl 24 mg/130 mg

110 mg/600 mg

200 mg/125 mg

400 mgi250 mg

160 mg

300 mg

5mg 10mg

25 kg 25 mg

1,450 mg

600 mg 750 mg

750 mg

1,000 mg

50 mg

2mg

220 mg

500 mg 500 mg

300 mg

325 mg

Tablet Norwich Eaton 0.80

Tablet Burroughs Wellcome 0.74

Tablet Marion 0.47

Tablet Marion 0.69

Tablet Lilly 0.75

Capsule Squibb 0.80

Tablet Schering 0.70

Knoll 0.24

Tablet Stuart 0.71

Tablet Fisons 0.67

Tablet Fisons 0.56

Tablet Ciba 0.68

Tablet (control) 0.48

Tablet Upjohn 0.65

Tablet McNeil 0.86 Tablet Smith, Kline, and French 0.68

Tablet Pfizer 1.08

Capsule Willen 0.61 Tablet Ciba 0.53

Tablet Adria 0.46

Tablet Abbott 0.42

Tablet Reed and Carnrick 0.73

Tablet Lilly 0.80

Capsule Mericon 0.61

Tablet

Tablet

Searle

Smith, Kline, and French

Tablet

Tablet

Tablet Tablet

Parke Davis

Stuart Miles

Generic

0.69 0.75

0.65 0.58

0.56

0.87 0.71

Tablet

Tablet

Tablet Tablet

Lilly

Winthrop Lilly

Lilly

- -

-

-

l From Handy CA. Radio-opacity of oral nonliquid medications. Radiology 1971;98:525-533.

TABLE 3. Drugs Found to Be Moderately Radiopaque

Generic Name

Acetazolamide Acetohexamide Acetophenazine Albuterol Allopurinol

Aluminaimagnesial simethicone

Aluminum carbonate Aluminum hydroxide/

magnesium hydroxide

Brand Name Strength Form Manufacturer

Diamox 250 mg Tablet Lederle Dymelor 250 mg Tablet Lilly Tindal 20 mg Tablet Schering Ventolin 2mg Tablet Glaxo Zyloprim 100 mg Tablet Burroughs Wellcome Maalox Plus 20012OOf25 mg Tablet Rorer

Basaljel 608 mg Capsule Wyeth Mylanta - Tablet Stuart

Optical Density

(Units)

0.95 1.06 0.87 1.08 1.17 0.77

0.91

0.86

304

Page 4: Detectability of drug tablets and capsules by plain radiography

O’BRIEN ET AL w DETECTABILITY OF TABLETS AND CAPSULES

TABLE 3-Continued

Generic Name Brand Name Strength Form Manufacturer

Optical

Density

(Units)

Amiloride

Amiloride/

hydrochlorothiazide Aminophylline

Amitriptyline

Amoxapine Amoxicillin

Amoxicillin/potassium

clavulanate

Amphetamine/

dextraoamphetamine

Ascorbic acid

Aspirin (buffered)

Aspirin (buffered)

Aspirin (enteric)

Bacampicillin

Benztropine

Bethanechol

Birth Control

Brompheniramine

phenylephrinel phenylpropanolamine

Butabarbital

Calcium gluconate Calcium lactate

Calcium polycarbophil

Chloramphenicol

Chloroquine phosphate Chlorothiazide

Chlorpheniramine

Chlorpheniramine/

pseudoephedrine

Chlorpropamide

Chlorzoxazone/ acetaminophen

Cimetidine

Clemastine/

phenylpropanolamine

Clindamycin Clofibrate

Clotrimazole

Cyclophosphamide

Cyproheptadine Danthron

Desipramine

Dextromethorphan/

phenylpropanolamine Dextrothyroxine Dicyclomine Dimenhydrinate

Dyphyllinelguaifenesin Ephedrine/theophylline/

hydroxyzine Ergotamine/caffeine Estrogens (conj)

Ethacrynic acid Ethambutol

Ethchlorvynol Ethinyl estradiol Etidronate

Fludrocortisone Fluphenazine

Midamor 5mg Tablet Merck, Sharp, and Dohme 0.68 Moduretic 5150 mg Tablet Merck, Sharp, and Dohme 0.79

-

-

Asendin

Amoxil Augmentin

200 mg Tablet Searle 0.71 10 mg Tablet Roxane 0.99 50 mg Tablet Lederle 0.83

250 mg Tablet Beecham 0.76 250 mg Tablet Beecham 0.92

Biphetamine 7.5 mg Capsule Pennwalt 0.92

-

Ascriptin AD

Ascriptin

Easprin

Spectrobid

Cogentin

Urecholine

Ovcon 35 Dimetapp Extentab

250 mg

325 mg

325 mg

975 mg

400 mg

1 mg

5mg -

Tablet Roxane 1.08 Tablet Rorer 1.21

Tablet Rorer 1.23

Tablet Parke-Davis 0.71

Tablet Roerig 1.26 Tablet Merck, Sharp, and Dohme 0.83

Tablet Merck, Sharp, and Dohme 0.91 Tablet Mead Johnson 0.91 Tablet A. H. Robins 1.14

Butisol -

-

Mitrolan

Chloromycetin -

Diuril

Chlortrimeton

Deconamine

15mg Tablet Wallace 0.84 1000 mg Tablet Westward 0.64 325 mg Tablet Lilly 0.65 500 mg Tablet A. H. Robins 1.17 250 mg Capsule Parke-Davis 1.06 500 mg Tablet Wyeth 0.62 500 mg Tablet Merck, Sharp, and Dohme 0.68

12mg Tablet Schering 0.78 4160 mg Tablet Berlex 0.67

Diabinese 250 mg Tablet Pfizer 0.70 Parafon Forte 250/300 mg Tablet McNeil 1.24

Tagamet Tavist-D

300 mg 1.34175 mg

Tablet

Tablet

Smith, Kline, and French Sandoz

0.74

0.73

Cleocin 150 mg Capsule Upjohn 1.14 Atromid-S 500 mg Capsule Ayerst 0.78 Mycelex 10mg Tablet Miles 1.12 Cytoxan 50 mg Tablet Mead Johnson 1.08 Periactin 4mg Tablet Merck, Sharp, and Dohme 1.04 Modane 75 mg Tablet Adria 0.85 Norpramin 75 mg Tablet Merrell 0.84 Ornacol 30125 mg Capsule Menley and James 0.77

Choloxin 1 mg Tablet Flint 0.72 Bentyl 20 mg Tablet Merrell Dow 0.89 Dramamine 50 mg Tablet Searle 0.88 Lufyllin GG 200/200 mg Tablet Wallace 0.71 Marax 25/l 30/l 0 mg Tablet Roerig 0.61

Cafergot l/100 mg Tablet Sandoz 0.78 Premarin 0.625 mg Tablet Ayerst 0.86 Edecrin 25 mg Tablet Merck, Sharp, and Dohme 1.17 Myambutol 400 mg Tablet Lederle 1 .Ol Placidyl 500 mg Capsule Abbott 0.88 Estinyl 0.02 mg Tablet Schering 0.44 Didronel 200 mg Tablet Norwich Eaton 1.09 Florinef 0.1 mg Tablet Squibb 0.91 Prolixin 2.5 mg Tablet Squibb 0.94

305

Page 5: Detectability of drug tablets and capsules by plain radiography

AMERICAN JOURNAL OF EMERGENCY MEDICINE n Volume 4, Number 4 n July 1986

TABLE 3-Continued

Generic Name Brand Name Strength Form Manufacturer

Optical

Density

(Units)

Folic acid

Glyburide

Glyburide Griseofulvin

Hydrochlorothiazide

Hydrocodonel phenyltoloxamine

Hydroxychloroquine

Hydroxyzine

lbuprofin

lbuprofin

lmipramine

Isometheptene/

dicloralphenazone/

acetaminophen Isoxsuprine

Ketoconazole

Lactobacillus

Lithium

Lithium

Maprotiline

Megaldrate

Megestrol

Mesoridazine

Metaproterenol

Methanamine/methylene

methazolamide

Methyldopa/

hydrochlorothiazide Methylergonovine blue/

phenylsalicylate/

benzoic acid/atropine/

hyoscyamine Methysergide

Metyrapone Mitotane

Multivitamins/iron

Multivitamins/minerals

Neomycin sulfate

Oxyphenbutazone Pancrelipase Penicillamine

Penicillin VK Pentazocine Pentoxifylline

Perphenazine/amitriptyline Perphenazine/amitriptyline

Phenobarbital/hyoscyamine/ atropine/scopolamine

Phytonadione

Primaquine phosphate Probenecid Probenecid/colchicine

Procainamide amitriptyline Propantheline bromide Propranolol/

hydrochlorothiazide Pyridostigmine Quinidine Ranitidine

306

Folvite

Diabeta Micronase Fulvicin -

Tussionex

1 w Tablet Lederle 0.87

5m9 Tablet Hoerchst-Roussel 0.81

5w Tablet Upjohn 0.95

250 mg Tablet Schering 0.97

50 mg Tablet Parke-Davis 0.71

5110 mg Tablet Pennwalt 0.69

Plaquenil

Atarax

Advil

Motrin -

Midrin

200 mg

25 mg

200 mg

400 mg

25 mg

65/l 001325 mg

Tablet

Tablet

Tablet

Tablet

Tablet

Capsule

Winthrop Pfizer

Whitehall

Upjohn

Geneva Carnrick

1.07

1.04

0.86

0.71

1.15

0.94

Vasodilan 10mg Tablet

Nizoral 200 mg Tablet Lactinex - Tablet

Mead Johnson Janssen

Hynson, Westcott, and Dunning

Smith, Kline, and French

Ciba

Ciba Ayerst

Mead Johnson

Boehringer lngelheim

Boehringer

Lederle

1.09 0.76 0.71

Eskalith CR

Lithobid

Ludiomil

Riopan

Megace

Serentil

Alupent

Neptazone

450 mg

300 mg 25 mg

480 mg 20 mg

50 mg

20 mg

50 mg

Tablet Tablet

Tablet

Tablet

Tablet

Tablet

Tablet

Tablet

0.88

0.80 0.76

0.83 0.84

0.88

1.06

0.96

Aldoril 250/25 mg Tablet Merck, Sharp, and Dohme 0.60

Methergine

Urised

Sansert

Metopirone Lysodren

Centrum Jr./Iron

Vicon-C

0.2 mg 40.815.41

4.510.31

0.3 mg

2mg 250 mg

500 mg -

Tablet Sandoz 0.93

-

-

Tanderil

Viokase Depen -

Talwin

Trentai Etrafon

Procan SR Donnatal

Extentabs

500 mg

100 mg -

Mephyton -

Benemid

Colbenemid Triavil

Probanthine lnderide

250 mg 250 mg

50 mg 400 mg

2110 mg 750 mg

48.610.311 0.0581

0.019 mg

5mg 26.3 mg 500 mg

0.510.5 mg

4125 mg 15mg

80125 mg

Tablet Webcon 0.74

Tablet Sandoz 0.66 Tablet Ciba 0.98 Tablet Bristol 0.72

Tablet Lederle 0.82

Capsule Glaxo 0.84

Tablet Roxane 1.03

Tablet Geigy 0.72

Tablet Viobin 0.71

Tablet Wallace 0.98 Tablet Squibb 1.08 Tablet Winthrop 1.10 Tablet Hoechst-Roussel 0.90 Tablet Schering 0.58 Tablet Parke-Davis 0.79

Tablet A. H. Robins 1.14

Tablet Merck, Sharp, and Dohme 1.15 Tablet Generic 0.83 Tablet Merck, Sharp, and Dohme 1.03 Tablet Merck, Sharp, and Dohme 0.74

Tablet Merck 0.84 Tablet Searle 0.77 Tablet Ayerst 0.68

Mestinon Quinidex Zantac

60 mg 300 mg 150 mg

Tablet Tablet Tablet

Roche A. H. Robins Glaxo

0.68 1.20 0.74

Page 6: Detectability of drug tablets and capsules by plain radiography

O’BRIEN ET AL n DETECTABILITY OF TABLETS AND CAPSULES

TABLE J-Continued

Generic Name Brand Name Strength Form Manufacturer

Optical

Density (Units)

Reserpine/hydralazine/

hydrochlorothiazide Reserpinei

hydrochlorothiazide

Sodium bicarbonate

Spironolactone/

hydrochlorothiazide Sulcrafate

Sulfadiazine

Sulfamethoxazole

Sulfapyridine

Sulfasalazine

Sulfisoxazole

Sulfisoxazolel

phenazopyridine Thiamine

Thioguanine Thioridazine

Tocainide

Tolazamide

Tolbutamide

Trazodone

Triamterenel

hydrochlorothiazide

Trihexyphenidyl

hydrochloride Trioxsalen

Trisalicylate

Triprolidine/

pseudoephedrine Verapamil Zomepirac

Ser-Ap-Es 0.1/25/15 mg Tablet Ciba 0.75

Hydropres 0.125/25 mg Tablet Merck, Sharp, and Dohme 0.67

- 325 mg Tablet Lilly 1.11 Aldactazide 25125 mg Tablet Searle 0.89

Carafate - Gantanol - SAS-500

Gantrisin

AzoGantrisin

- - Mellaril

Tonocard

Tolinase -

Desyrel

Maxzide

Artane 2mg Tablet Lederle 0.56

Trisoralen 5mg Tablet Elder 1.13 Trilisate 750 mg Tablet Purdue Frederick 0.84 Actifed 2.5/60 mg Tablet Burroughs Wellcome 1.17

Calan Zomax

TABLE 4. Drugs Found to Be Not or Minimally Radiopaque

lg Tablet Marion 0.69 500 mg Tablet Lilly 0.69 500 mg Tablet Roche 0.73 500 mg Tablet Lilly 0.70 500 mg Tablet Rowell 0.69 500 mg Tablet Roche 0.98

500/50 mg Tablet Roche 0.75

100 mg Tablet Westward 1 .oo 40 mg Tablet Burroughs Wellcome 0.67 50 mg Tablet Sandoz 0.87

400 mg Tablet Merck, Sharp, and Dohme 0.93 250 mg Tablet Upjohn 0.82 500 mg Tablet Ascot 0.67

50 mg Tablet Mead Johnson 0.78 75150 mg Tablet Lederle 0.64

120 mg

100 mg

Tablet Tablet

Searle

McNeil 1.12

0.95

Generic Name Brand Name Strength Form Manufacturer

Optical Density

(units)

Acetaminophen Acetaminophen

Acetaminophen Acetaminophen

Acetaminophen Acetaminophen/codeine Activated charcoal Acyclovir

Alprazolam

Alprazolam

Amantadine

Aminocaproic acid Aminoglutethimide Amobarbital Amoxicillin

Amphetamine Ampicillin Aspirin Aspirin Aspirin (buffered) Aspirin/codeine

Tylenol Tylenol

Tylenol Phenathen

St. Joseph Tylenol No. 3 - Zovi rax

Xanax

Xanax Symmetrel

Amicar

Cytadren Amytal Polymox Dexadrine

Principen Bayer Encaprin Bufferin Empirin 3

160 mg

325 mg

500 mg 325 mg

80 mg 300130 mg

260 mg

200 mg 0.25 mg

0.5 mg 100 mg

500 mg

250 mg 50 mg

250 mg 15mg

250 mg 325 mg 500 mg

324 mg 300130 mg

Tablet

Tablet

Caplet

Capsule Tablet

Tablet

Capsule Capsule Tablet

Tablet

Tablet

Tablet Tablet

Capsule Capsule Tablet Tablet Capsule Tablet Tablet

McNeil 0.92

McNeil 0.88 McNeil 0.70 AH Robins 0.90 Plough 1.09 McNeil 1.01

Generic 0.85 Burroughs Wellcome 0.84

Upjohn 0.95

Upjohn 0.89 DuPont 0.77

Lederle 1.18

Ciba 1.18 Lilly 0.81 Bristol 0.67 Smith, Kline, and French 1.02

Squibb 1.15 Bayer 0.79 Norwich Eaton 1 .oo Brisol-Myers 1.17 Burroughs Wellcome 0.73

307

Page 7: Detectability of drug tablets and capsules by plain radiography

AMERICAN JOURNAL OF EMERGENCY MEDICINE n Volume 4, Number 4 n July 1986

TABLE 4-Conrinued

Generic Name Brand Name Strength Form Manufacturer

Optical Density

(Units)

Aspirin (enteric)

Atenolol

Atropine sulfate

Azatadine Azathioprine

Baclofen

Benzonatate

Betacarotene

Bioflavonoids

Birth control Birth control

Birth control Birth control

Birth control/iron

Bisacodyl Bromocriptine

Bumetanide

Bumetanide

Butalbital/aspirin/caffeine

Calcitriol

Captopril

Caramithen/phenylpropanolamine

Carbamazepine Carbenicillin

Carbidopatlevodopa Carbinoxamine/pseudoephedrine Carisoprodol

Carisoprodol/aspirin Carisoprodol/aspirin/Codeine

Cefaclor Cefradroxil

Cephalexin Cephradine

Chlorambucil

Chlordiazepoxide Chlordiazepoxide

Chlordiazepoxide/amitriptyline Chlordiazepoxideiclidinium

Chlorpheniramine

Chlorpheniraminelphenyltoloxaminei phenylephrine

Chlorpheniramine/pseudoephedrine Chlorpromazine Chlorthalidone

Clemastine fumarate

Clomiphene citrate

Clonazepam Clonidine

Clorazepate

Codeine Colchicine

Cortisone acetate Cromolyn sodium Cyclacillin Cyclandelate Cyclizine Cyclobenzaprine Danocrine Dantrolene

Dapsone Dexamethasone Dextroamphetamine

308

Ecotrin

Tenormin -

Optimine

lmuran

Lioresal

Tessalon

Solatene -

Ortho-Novum Tri-Norinyl Norinyl 1 + 50

Ortho Novum 7/7/7

Loestrine Fe Dulcolax

Parlodel

Bumex

Bumex Fiorinal

Rocaltrol

Capoten

Tuss-Ornade

Tegretol

Geocillin

Sinemet Rondec TR

Soma Soma Compound

Soma with Codeine Ceclor

Ultracef

Keflex

Velosef

Lukeran -

-

Limbritol

Librax Teldrin

Comhist LA

Deconamine SR Thorazine Thalitone

Tavist -

Clonopin

Catapres Tranxene - - -

lntal

Cyclapen Cyclospasmol Marezine Flexeril Danazol Dantrium -

Hexadrol Dexedrine

325 mg 50 mg

0.3 mg

1 mg 50 mg

20 mg

100 mg

30 mg -

10111 mg -

- -

1.5130 mg

5mg 2.5 mg

1 mg 0.5 mg

501325/40 mg

0.25 kg

25 mg

40175 mg

200 mg

382 mg 25/l 00 mg

8/l 20 mg

350 mg 200/325 mg

200/325/l 6 mg 250 mg

500 mg

250 mg

500 mg

2mg 10mg

25 mg

5112.5 mg

512.5 mg

8mg 4150120 mg

81120 mg Capsule 75 mg Capsule 25 mg Tablet

2.68 mg Tablet 50 mg Tablet

0.5 mg Tablet 0.1 mg Tablet 7.5 mg Capsule 15mg Tablet

0.6 mg Tablet

5mg Tablet 20 mg Capsule

250 mg Tablet 400 mg Capsule

50 mg Tablet 10 mg Tablet

200 mg Capsule 25 mg Capsule 25 mg Tablet

4mg Tablet 15mg Capsule

Tablet

Tablet

Tablet

Tablet

Tablet

Tablet

Capsule

Capsule

Capsule Tablet

Tablet Tablet

Tablet Tablet

Tablet

Tablet

Tablet

Tablet

Tablet

Capsule

Tablet

Capsule

Tablet

Tablet Tablet

Tablet Tablet

Tablet

Tablet

Capsule

Capsule

Capsule

Tablet

Capsule

Capsule

Tablet

Capsule

Capsule Capsule

Menley and James 0.88

Stuart 0.92

Generic 0.80 Schering 0.86 Burroughs Wellcome 1.03

Geigy 1 .oo

DuPont 0.84

Roche 1.22

Beutlich 0.65

Ortho 0.89 Syntex 0.64

Syntex 0.75

Ortho 0.84

Parke-Davis 0.96 Boehringer lngelheim 0.69

Sandoz 0.89

Roche 1.22

Roche 1.21

Dorsey 0.87

Roche 1.05

Squibb 1.19

Smith, Kline, and French 1.18

Geigy 0.85 Roerig 1.12

Merck, Sharp, and Dohme 0.70

Ross 0.87 Wallace 0.93

Wallace 0.86

Wallace 0.89 Lilly 1.08

Bristol 0.96 Dista 1.05

Squibb 1 .Ol

Burroughs Wellcome 0.73

Ascot 1.07

Parke-Davis 1 .Ol

Roche 0.78

Roche 0.93 Smith, Kline, and French 1.14

Norwich Eaton 0.91

Berlex 0.77

Smith, Kline, and French 0.99 Boehringer lngelheim 0.90 Sandoz 0.86 Merrell 0.76

Roche 0.79 Boehringer lngelheim 0.79

Abbott 0.89 Wyeth 0.92 Lilly 0.90

Upjohn 0.93 Fisons 1.37 Wyeth 1.26 Ives 0.78 Burroughs Wellcome 0.61 Merck, Sharp, and Dohme 1.16 Wyeth 0.84 Norwich Eaton 1.07 Jacobus 0.98 Organon 0.89 Smith, Kline, and French 0.75

Page 8: Detectability of drug tablets and capsules by plain radiography

O’BRIEN ET AL n DETECTABILITY OF TABLETS AND CAPSULES

TABLE 4-Continued

Generic Name Brand Name Strength Form Manufacturer

Optical

Density

(units)

Diazepam

Diazepam

Diazoxide

Dicloxacillin

Dicyclomine

Dicyclomine

Diethylstilbesterol

Diflunisal Digitoxin

Digoxin Dihydrocodeine/aspirin/caffeine

Dihydrotachysterol

Diltiazem

Diphenhydramine

Diphenoxylate/atropine

Disopyramide

Docusate

Doxepin

Doxepin

Doxycycline

Dypridamole

Ephedrine sulfate Ergocalciferol

Ergoloid mesylates Ergoloid mesylates

Erythromycin

Erythromycin Estramustine

Estropipate

Ethosuximide

Fenoprofen Flucytosine

Fluoxymesterone

Flurazepam

Furosemide

Gelatin Gemfibrozil

Glipizide Glutethamide

Guanabenz

Guanadrel Guanethidine

Hydralazine

Hydrocortisone

Hydromorphone

Hydroxyurea

Hyoscyamine Hyroxyzine

lndapamide

lndomethacin lndomethacin lsoniazid

lsosorbide dinitrate

lsotretinoin Labetalol Levodopa Levophanol Levothryoxine

Lincomycin Lomustine

Loperamide Lorazepam

Valium

Valrelease

Proglycem

Dynapen

Bentyl

Bentyl -

Dolobid -

Lanoxin

Synalgos DC DHT

Cardiazem

Benadryl

Lomotil

Norpace CR

Colace

Sinequan

Adapin

Vibratabs Persantine -

Drisdol

Hydergine Hydergine

EES ERYC

Emcyt Ogen

Zarontin Nalfon

Ancobon Malotestin

Dalmane

Lasix -

Lopid Glucotrol Doriden

Wytensin Hylorel

lsmelin -

Hydrocortone Dilaudid

Hydrea Levsin

Vistaril

Lozol lndocin SR

lndocin -

Sorbitrate

Accutane Normodyne Dopar Levo-Dromoran

Synthroid Lincocin

Ceenu lmodium Ativan

5 mg Tablet Roche 0.88 15mg Capsule Roche 0.82

500 mg Capsule Schering 1.21

250 mg Capsule Bristol 1.08

10mg Capsule Merrill Dow 1 .Ol

20 mg Tablet Merrell Dow 0.89

5 mg Tablet Lilly 1.11

500 mg Tablet Merck, Sharp, and Dohme 1 .oo 0.1 mg Tablet Purepac 0.84

0.125 mg Tablet Burroughs Wellcome 1.21 161356.4130 mg Capsule Ives 1.03

0.2 mg Tablet Roxane 1.20 30 mg Tablet Marion 0.77 25 mg Capsule Parke-Davis 1.24

2.5iO.025 mg Tablet Searle 0.83 100 mg Capsule Searle 1.24 100 mg Capsule Meade Johnson 1.21

25 mg Capsule Roerig 1.12 25 mg Capsule Pennwalt 0.70

100 mg Tablet Pfizer 0.95

50 mg Tablet Boehringer lngelheim 0.68

25 mg Capsule Lilly 0.74 1.25 mg Capsule Wyeth 0.73

1 mg Capsule Sandoz 0.77

1 mg Tablet Sandoz 0.86 400 mg Tablet Abbott 0.88

250 mg Capsule Parke-Davis 0.98 140 mg Capsule Roche 0.98

0.625 mg Tablet Abbott 0.91 250 mg Capsule Parke-Davis 0.69

300 mg Capsule Dista 0.90

500 mg Capsule Roche 0.83

10mg Tablet Upjohn 1.11

30 mg Capsule Roche 1.03 40 mg Tablet Hoechst 0.66

empty #4 Capsule Generic 0.74

300 mg Capsule Parke-Davis 1.13

5mg Tablet Pfizer 0.84

500 mg Tablet usv 0.98

4mg Tablet Wyeth 1.17 10mg Tablet Pennwalt 0.92 10 mg Tablet Ciba 0.90 25 mg Tablet Rugby 1.27

10mg Tablet Merck, Sharp, and Dohme 1.04

1 w Tablet Knoll 0.80

500 mg Capsule Squibb 1.02 0.125 mg Tablet Kremers-Urban 0.82

50 mg Capsule Pfizer 0.95

2.5 mg Tablet USV Pharmaceuticals 0.90 75 mg Capsule Merck, Sharp, and Dohme 0.84

25 mg Capsule Merck, Sharp, and Dohme 0.88 100 mg Tablet Lilly 0.77

5mg Tablet Stuart 0.62 40 mg Tablet Roche 1.18

200 mg Tablet Schering 0.81 250 mg Capsule Eaton 1.08

2 mg Tablet Roche 0.82 0.1 mg Tablet Flint 0.80

250 mg Tablet Upjohn 0.68 10 mg Capsule Bristol 0.63

2 mg Capsule Janssen 0.90

t mg Tablet Wyeth 1.12

309

Page 9: Detectability of drug tablets and capsules by plain radiography

AMERICAN JOURNAL OF EMERGENCY MEDICINE H Volume 4, Number 4 n July 1988

TABLE 4-Continued

Generic Name Brand Name Strength Form Manufacturer

Optical

Density (units)

Loxapine

Mebendazole

Meclofenamate

Medroxyprogesterone Mefanamic acid

Melphalan Meperidine

Meprobamate

Meprobamatelaspirin

Mercaptopurine

Methadone

Methamphentamine

Methaqualone

Metharbital Methenamine mandelate

Methenytoin

Methimazole

Methobarbital Methocarbamol

Methocarbamol/aspirin Methotrexate

Methoxsalen

Methsuximide Methyclothiazide

Methyldopa Methylprednisolone

Methyltesterone

Metoclopramide

Metolazone

Metoprolol

Metronidazole

Metronidazole Metyrosine

Minocycline Minoxidil Multivitamins Multivitamins

Nadolol

Nadololibendroflumethiazide

Naltrexone

Naproxen

Naproxen (sodium) Neostigmine Niacin

Nifedipine

Nitrofurantoin Nitroglycerin

Nitroglycerin Nitroglycerin Norethindrone Nortriptyline Nylidrin Nystatin Orphenadrine

Orphenadrine/aspirin/caffeine Oxacillin

Oxandrolone Oxazepam Oxtriphylline Oxybutnin

Cxycodone/acetaminophen Dxycodone/acetaminophen

310

Loxitane

Vermox

Meclomen

Provera

Ponstel Alkeran -

Equanil Equagesic

Purinethol

Dolophine

Desoxyn -

Geomonil

Mandelamine

Mesantoin

Tapazole Mebaral

Robaxin Robaxisal -

Oxsoralen Celontin

Enduron

Aldomet

Medrol -

Reglan

Zaroxolyn

Lopressor

Protostat

Flagyl Demsar Minocin Loniten -

Albee with C Corgard

Corzide

Trexan Naprosyn

Anaprox Prostigmin -

Procardia

Macrodantin

Nitrostat SR Nitrostat

Nitrobid

Aygestin Pamelor

Arlidin

10mg

100 mg

100 mg

10mg

250 mg

2mg 50 mg

200 mg

2001325 mg 50 mg

5mg

5mg 150 mg

100 mg

500 mg

100 mg

10mg 32 mg

750 mg

4001325 mg 2.5 mg

10mg

150 mg

5mg 250 mg

32 mg

10mg

10mg

2.5 mg

50 mg

250 mg

250 mg 250 mg

50 mg

2.5 mg - -

40 mg

4015 mg

400 mg 250 mg

275 mg

14mg

100 mg

10 mg 50 mg

6.5 mg

0.4 mg 2.5 mg

5mg 75 mg

6mg - 500,000 u Norflex 100 mg

Norgesic Forte 50/770/60 mg Prostaphlin 250 mg Anavar 2.5 mg Serax 30 mg

Choledyl SA 400 mg Ditropan 5mg Tylox 51500 mg Percocet 51300 mg

Capsule

Tablet

Capsule

Tablet

Capsule Tablet Tablet

Tablet

Tablet

Tablet

Tablet

Tablet

Tablet

Tablet

Tablet

Tablet Tablet

Tablet

Tablet Tablet

Tablet

Capsule Capsule

Tablet

Tablet

Tablet

Tablet

Tablet Tablet

Tablet

Tablet Tablet

Capsule Capsule Tablet

Tablet

Capsule Tablet

Tablet

Tablet

Tablet

Tablet

Tablet

Tablet Capsule

Capsule Capsule Tablet

Capsule

Tablet Capsule Tablet Tablet

Tablet Tablet

Capsule Tablet Capsule Tablet Tablet Capsule Tablet

Lederle 1.01

Janssen 0.80

Parke-Davis 0.89

Upjohn 0.86

Parke-Davis 0.98

Burroughs Wellcome 0.68

Wyeth 0.78

Wyeth 0.88

Wyeth 1.22

Burroughs Wellcome 0.78

Lilly 0.93

Abbott 0.99

Rorer 0.88

Abbott 0.82

Parke-Davis 1.00

Sandoz 1.08

Lilly 0.76

Breon 0.97

AH Robins 0.78

AH Robins 0.88 Generic 1.02

Elder 0.80

Parke-Davis 0.78

Abbott 0.69

Merck 0.88

Upjohn 0.93

Schering 0.70

AH Robins 1.07

Pennwalt 0.90

Geigy 1.12

Ortho 0.91

Searle 0.78

Merck, Sharp, and Dohme 0.93

Lederle 0.86 Upjohn 0.84 Rowell 0.91

AH Robins 0.97

Squibb 0.93

Squibb 0.76

DuPont 0.94

Syntex 0.75

Syntex 1.22 Roche 0.66

Roxane 1.03 Pfizer 0.80 Norwich Eaton 1.05

Parke-Davis 1.07

Parke-Davis 1.27 Marion 1.13

Ayerst cl.97 Sandoz 0.96 usv 0.90 Squibb 0.88 Riker 1.09 Riker 0.74 Bristol 1.07

Searle 0.81 Wyeth 0.69 Parke-Davis 1.16 Marion 0.90 McNeil 0.87 DuPont 1.04

Page 10: Detectability of drug tablets and capsules by plain radiography

O’BRIEN ET AL D DETECTABILITY OF TABLETS AND CAPSULES

TABLE 4-Continued

Generic Name Brand Name Strength Form Manufacturer

Optical

Density

(Units)

Oxycodonelaspirin

Oxymetholone

Pancrelipase

Papaverine hydrochloride Pemoline

Pentaerythritol tetranitrate

Pentobarbital Phenobarbital

Phenoxybenzamine

Phentermine

Phenylbutazone

Phenylephrine/phenylpropanolamine/

quaifensin

Phenylpropanolaminel

chlorpheniramine

Phenylpropanolamine/phenylephrine/

phenyltoloxamine/ chlorpheniramine

Phenytoin

Phenytoin Pindolol

Piroxicam

Prazepam Prazosin

Prednisolone

Prednisone

Primidone

Probucol

Procarbazine

Prochlorperazine

Prochlorperazine/isopropamide Procyclidine

Promethazine

Propoxyphene

Propoxyphene/acetaminophen

Propranolol Propylthiouracil Pseudoephedrine

Pseudoephedrine/chlorpheniramine

Pyridoxine hydrochloride

Pyrimethamine

Pyrvinium

Quinestrol

Quinidine

Quinidine gluconate

Quinidine sulfate Reserpine Riboflavin Rifampin

Salsalate Secobarbital Senna concentrate

Sodium fluoride

Sumnpyrazone Sulindac Tamoxifen

Temazepam

Terbutaline Tetracycline Theophylline Theophylline Theophylline

Percodan Anadrol

Pancrease -

Cylert Peritrate Nembutal -

Dibenzyline

Fastin Butazolidin

Entex

5f300 mg Tablet

50 mg Tablet - Capsule

100 mg Tablet 37.5 mg Tablet

20 mg Tablet

100 mg Capsule 15mg Tablet

10mg Capsule 30 mg Capsule

100 mg Tablet 5/45/200 mg Capsule

Ornade 75/l 2 mg Capsule

Naldecon 40/l O/l 515 mg Tablet

Dilantin

Dilantin

Visken Feldene

Centrax Minipress -

Deltasone

Mysoline

Lorelco

Matulane

Compazine

Combid Kemadrin

Phenergan

Darvon

Darvocet-N 100 lnderal LA -

Novafed

Novafed A -

Daraprim

Povan Estrovis

Quinaglute

Quinaglute -

-

-

Rifadin Disalcid

Seconal

Senokot Luride

Anturane Clinoril Nolvadex

Restoril

Brethine Sumycin Elixophyllin SR

Slobid Slophyllin

100 mg Capsule

30 mg Capsule

5mg Tablet

20 mg Capsule

5mg Capsule

1 mg Capsule

5mg Tablet

10 mg Tablet

50 mg Tablet

250 mg Tablet

50 mg Capsule 10mg Capsule

1 O/5 mg Capsule

5mg Tablet

25 mg Tablet

65 mg Capsule 100/650 mg Tablet

60 mg Capsule 50 mg Tablet

120 mg Capsule 120/6 mg Tablet

25 mg Tablet

25 mg Tablet

50 mg Tablet

0.1 mg Tablet

324 mg Tablet

325 mg Tablet

200 mg Tablet 0.1 mg Tablet 10mg Tablet

300 mg Capsule 750 mg Table:

50 mg Capsule - Tablet

2.2 mg Tablet

200 mg Capsule 200 mg Tablet

10 mg Tablet

15mg Capsule

5mg Tablet

250 mg Capsule 250 mg Capsule 100 mg Capsule 60 mg Capsule

Dupont 0.66

Syntex 0.75 McNeil 1.11 Lilly 0.94

Abbott 1.03 Parke-Davis 7.10

Abbott 1.04 Parke-Davis 0.96 Smith, Kline, and French 1.02

Beecham 0.97

Geigy 1.15

Norwich Eaton 0.92

Smith, Kline, and French 1.11

Bristol 1.04

Parke-Davis 1 .oo Parke-Davis 1 .oo Sandoz 1.16

Pfizer 0.77 Parke-Davis 0.66 Pfizer 0.75

Roxane 1.01

Upjohn 1.14

Ayerst 0.92 Merrell Dow 1 .os

Roche 1.20

Smith, Kline, and French 0.99

Smith, Kline, and French 1.22 Burroughs Wellcome 0.62

Wyeth 0.66 Lilly 0.92 Lilly 0.96

Ayerst 1.24 Lilly 0.60

Dow 0.67

Dow 0.87 West-Ward 0.80 Burroughs Wellcome 0.88 Parke-Davis 0.86 Parke-Davis 0.92

Berlex 0.76

Berlex 0.74

Whitehall 0.75 West-Ward 0.97 Lilly 1.10

Ciba 1.18

Riker 1.18 Lilly 0.74

Purdue 0.96

Hoyt 1.08

Ciba 0.74 Merck, Sharp, and Dohme 1.25

Stuart 0.81

Sandoz 1.26

Geigy 0.98

Squibb 0.89 Berlex 1.14

Rorer 0.99 Rorer 0.73

311

Page 11: Detectability of drug tablets and capsules by plain radiography

AMERICAN JOURNAL OF EMERGENCY MEDICINE w Volume 4, Number 4 n July 1986

TABLE 4-Continued

Generic Name Brand Name Strength Form Manufacturer

Optical Density

(Units)

Theophylline

Theophylline Theophylline

Theophylline/ephedrine/

phenobarbital Thiothixene

Thyroglobulin

Thyroglobulin

Thyroid

Timolol

Timololihydrochlorothiazide

Tolmetin Triamcinolone

Triamterene

Triamterene/hydrochlorothiazide Triflupromazine

Trimeprazine

Trimethobenzamide Trimethoprim

Trimethoprim/sulfa

Trimipramine Tripelenamine

Valproic acid

Verapamil

Vitamin A

Vitamin E Vitamin E

Vitamins

Vitamins/fluoride

Warfarin

Yeast

Somophyllin-T Theo-Dur

Theo-Dur Sprinkle

Tedral

Navane

Proloid

Proloid - Blocadren

Timolide

Tolectin Aristocort

Dyrenium

Dyazide Vesprin

Temaril Tigan

Proloprim

Bactrim DS

Sumontil

PBZ Depakene

lsoptin

Aquasol A - - Polyvisol

Polyviflor Coumadin -

200 mg Capsule 200 mg Tablet

125 mg Capsule 13012418 mg Tablet

2m9 32 mg

65 mg

60 mg

10mg

1 O/25 mg

400 mg

2mg 100 mg

50125 mg

10mg

5mg 250 mg 200 mg

160/800 mg

50 mg

25 mg 250 mg

80 mg

25,000 U

100 IU

100 IU -

1 mg 5 mg

450 mg

Capsule

Tablet Tablet

Tablet

Tablet

Tablet

Capsule Tablet

Capsule

Capsule Tablet

Capsule Capsule

Tablet Tablet

Capsule Tablet

Capsule Tablet

Capsule

Capsule Capsule

Tablet

Tablet Tablet

Tablet

Fisons 1.25

Key 1.00

Key 1.23

Parke-Davis 0.77

Roerig 1.25

Parke-Davis 1.07

Parke-Davis 0.81

Armour 1.02

Merck, Sharp, and Dohme 0.86

Merck, Sharp, and Dohme 0.75 McNeil 1.33

Lederle 0.83 Smith, Kline, and French 1 .oo Smith, Kline, and French 1.33

Squibb 0.84

Smith, Kline, and French 0.88 Beecham 0.86 Burroughs Welcome 0.81

Roche 0.88

Ives 0.63

Geigy 0.80

Abbott 1 .Ol

Knoll 1 .oo

Armour 0.76

Generic 0.69 Generic 0.99 Mead Johnson 0.98

Mead Johnson 1.04

DuPont 0.88 Lee 0.84

Despite these limitations, while a negative film of the abdomen is of little help to the emergency physi- cian in the overdose victim, the positive detection of drugs on a radiograph of the abdomen will aid in the determination of the amount of drug taken and the ef- ticacy of gastric emptying by lavage or emesis. The list of radiopaque medications produced by this study will help guide the emergency physician in ordering of such radiographs in an efficient and cost-effective fashion, and perhaps this list will improve the care of the overdose or poisoned patient.

The authors thank Ms. Selma Etter and Mr. Jerry Troutman for their help in the development of this project.

REFERENCES

1. Handy CA. Radio-opacity of oral nonliquid medications. Ra-

diology 1971;98:525-533.

2. Raymond CW. Iron poisoning: Assessment of radiography in diagnosis and management. Clin Pediatr 1979;18:614- 616.

3. Staple TW, McAlister WH. Roentgenographic visualization

of iron preparations in the gastrointestinal tract. Radi- ology 1964;83:1051-1056.

312